Biofourmis, a Boston-based global leader in virtual care and digital therapeutics, announced July 29 the company’s BiovitalsHF solution is the first-ever heart failure digital therapeutic to receive a Breakthrough Device designation from the U.S. Food and Drug Administration.
Amanda Powers-Han, Senior Partner and Chief Marketing Officer for Greater Than One, explores some real-life technology applications that are transforming healthcare today and tomorrow.
Jaydev Thakkar was named chief operating officer and Milan Shah was appointed chief technology officer of Biofourmis
Over the last few years, there has appeared to be big interest on the part of biopharma in leveraging artificial intelligence (AI) and machine learning to improve trial design and speed up drug development. Another related category is digital therapeutics (DTx), which the Digital Therapeutics Alliance says, “deliver evidence-based therapeutic interventions to patients that are driven by high quality software programs to prevent, manage or treat a broad spectrum of physical, mental and behavioral conditions.”
FreshBlood Group’s Bob Finkel shares his thoughts on various industry topics including the youth vaping epidemic and the complexities in promoting CBD-based products.
I got into Healthcare six years ago and canvassed major events to gain a consensus on what the future held.